Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32512 total
AST SpaceMobile reports tonight with its structural short position essentially unchanged — and a borrow market that has opened just enough to matter, but not enough to defuse the tension. The positioning story enters…
Sana Biotechnology heads into its August 11 earnings print as one of the most heavily shorted small-cap biotechs in the gene-therapy space, with the stock's brief recovery doing little to shake a persistently bearish…
Olema Pharmaceuticals heads into its August 14 earnings report carrying one of the heavier short burdens in clinical-stage biotech — and a Street consensus that disagrees sharply with the bears. Short interest is the…
HPK heads into today's earnings release as a rare bright spot in a sector that spent last week falling. The stock's 13% climb over the past week stands in direct contrast to its closest peers, which all moved lower.…
Silence Therapeutics heads into its August 12 results with the stock in the middle of one of its sharpest rallies in recent memory — and the insider register telling a story that cuts against the bullish momentum. The…
Rackspace Technology reports today with short sellers holding an unusually large position — and insiders heading for the exits — making this print a genuine test of whether a dramatic year-to-date rally has any…
Cogent Biosciences heads into its August 13 print with the most call-skewed options market in a year — but a 10% short base and a November FDA decision that dwarfs anything the quarterly numbers can deliver. The…
Red Cat Holdings reported earnings on August 6 and gained 6.4% on the day — and the setup heading into the next print on August 14 is, if anything, more charged than before. The post-earnings rally extended sharply.…
Alcon reports second-quarter results on August 11 carrying the weight of a bruising prior print and a stock that is still well below where it started the year. The most striking feature of the setup is what happened…
Kodiak Sciences reports Q2 results on August 14 carrying one of the more charged short-interest profiles in small-cap biotech, with nearly a fifth of its free float bet against it heading into a binary data…
GRAL reports after the close on August 12 carrying one of the most heavily hedged options setups it has seen all year — a notable signal for a stock already under significant short-seller pressure. The clearest…
Board member Keith Meister filed disclosures last week showing he sold over $143M worth of ILMN stock. The transactions took place August 4–5. Meister, representing an asset management firm on Illumina's board,…
Red Violet heads into its August 14 earnings report with the short-selling picture having changed dramatically since the bullish preview published just five days ago — a sharp reversal that now adds a new layer of…
Bain Capital Specialty Finance heads into its Q2 earnings release with options traders more anxious than at any point in the past year. The clearest signal comes from the options market. The put/call ratio spiked to…
YETI heads into its August 13 earnings print as one of the more genuinely contested consumer discretionary names in the market right now. The most striking recent development is on the analyst side. Goldman Sachs…
PennantPark Floating Rate Capital reports fiscal Q3 results on August 11 with options positioning skewed bullishly and the borrow market notably looser than it was a month ago. The clearest positioning signal is in…
GDOT heads into its August 13 earnings release with options traders notably more cautious than they have been all year. The sharpest signal is in options positioning. The put/call ratio has climbed to 0.30 — nearly…
Mistras Group reports Q2 results on August 11 with options traders notably more cautious than usual, even as short sellers show limited conviction and borrow conditions remain loose. The most telling signal heading…
Tenax Therapeutics heads into its August 13 earnings report as one of the most dramatic single-week collapses in the biotech space, with a 90% price drop forcing a complete re-read of the positioning signals that…
HROW reports today with a short position that has barely budged since yesterday's preview — and the lending market remains tight enough to make a short squeeze a live risk if the print surprises. Short interest is…
